Highlights and Quick Summary
- Operating CF/Net income for the quarter ending February 28, 2023 was 2.63 (a 304.97% increase compared to previous quarter)
- Year-over-year quarterly Operating CF/Net income increased by 15.05%
- Annual Operating CF/Net income for 2022 was 2.54 (a 1059.26% increase from previous year)
- Annual Operating CF/Net income for 2021 was 0.22 (a -34.01% decrease from previous year)
- Annual Operating CF/Net income for 2020 was 0.33 (a -90.99% decrease from previous year)
- Twelve month Operating CF/Net income ending February 28, 2023 was 3.78 (a 27.74% increase compared to previous quarter)
- Twelve month trailing Operating CF/Net income increased by 463.65% year-over-year
Trailing Operating CF/Net income for the last four month:
| 28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
|---|---|---|---|
| 3.78 | 2.96 | 2.54 | 0.67 |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating CF/Net income of Organigram Holdings Inc.
Most recent Operating CF/Net incomeof OGI including historical data for past 10 years.Interactive Chart of Operating CF/Net income of Organigram Holdings Inc.
Organigram Holdings Inc. Operating CF/Net income for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 2.63 | – | – | – | – |
| 2022 | 0.65 | 3.21 | 2.29 | 0.17 | 2.54 |
| 2021 | 7.16 | 0.27 | 2.72 | 0.16 | 0.22 |
| 2020 | -0.01 | 0.7 | -0.11 | 1.67 | 0.33 |
| 2019 | 15.84 | 0.69 | -0.31 | 1.14 | 3.68 |
| 2018 | – | – | -0.5 | -0.7 | -0.62 |
| 2017 | – | – | – | – | 0.82 |
| 2016 | – | – | – | – | -2.56 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic